- Category
- Micro (2020-21)
- Udyam number
- UDYAM-DL-11-0010213

Cavaxa Biotech Private Limited
About Cavaxa Biotech Private Limited
Data last updated:
Cavaxa Biotech Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 02 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC376373.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jayram Kumar and Santosh Kumar Singh.
Its last annual general meeting (AGM) was held on 17 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Chotu Ram Sangwan Plot No – 4 F/F Dewan Estate Bhagwati Garden Uttam Nagar, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹8,240 (net margin 0.1%) and EBITDA of ₹1.1 Lakh (EBITDA margin 1.1%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years.
Cavaxa Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0010213).
Company details
Recognitions & Rankings of Cavaxa Biotech
Contact details
Cavaxa Biotech Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressC/O Chotu Ram Sangwan Plot No – 4 F/F Dewan Estate Bhagwati Garden Uttam Nagar, New Delhi, Delhi, India – 110059
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cavaxa Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Cavaxa Biotech Private Limited, buy the company report.
Financials of Cavaxa Biotech Private Limited
FY 2025 filings availableCavaxa Biotech Private Limited reported revenue of ₹1.03 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 33%. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹8,240 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.1% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cavaxa Biotech Private Limited, buy the company report.
Board of directors of Cavaxa Biotech Private Limited
Cavaxa Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jayram Kumar | Director | 02 Feb 2021 | 5 Years 9 Months | Current |
| Santosh Kumar Singh | Director | 02 Feb 2021 | 5 Years 9 Months | Current |
Peer comparison
Cavaxa Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gaarnis Pharma Private Limited | ₹1.04 Cr (FY 2024) | -16.0% | Kochi, Kerala, India | |||
| Genex Laboratories Private Limited | ₹1.04 Cr (FY 2025) | -85.0% | Hyderabad, Telangana, India | |||
| Aydis Labs Private Limited | ₹1.03 Cr (FY 2024) | 96.0% | Saha, Haryana, India | |||
| Metafaabex Industries Private Limited | ₹1.03 Cr (FY 2025) | -21.0% | New Delhi, Delhi, India | |||
| Manish Biochem Products Pvt.Ltd. | ₹1.03 Cr (FY 2024) | 93.0% | Kolkata, West Bengal, India | |||
| Cavaxa Biotech Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹8,240 | 0.1% | -2.0% | New Delhi, Delhi, India | |
| Rankers Herbal Private Limited | ₹1.03 Cr (FY 2024) | -67.0% | Gandhidham, Gujarat, India | |||
| Niyamba Pharmaceutical Private Limited | ₹1.03 Cr (FY 2025) | 2.0% | Satna, Madhya Pradesh, India | |||
| Pfleger Healthcare Private Limited | ₹1.03 Cr (FY 2025) | 38.0% | Nashik, Maharashtra, India | |||
| Acube Innotech Private Limited | ₹1.03 Cr (FY 2024) | Noida, Uttar Pradesh, India | ||||
| Medill Pharma Private Limited | ₹1.03 Cr (FY 2025) | 23.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Cavaxa Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cavaxa Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cavaxa Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Cavaxa Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Cavaxa Biotech Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Jayram Kumar was appointed as Director on 02 Feb 2021.
Frequently asked questions
Cavaxa Biotech is an active private limited company based in New Delhi, Delhi, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 02 February 2021 (5+ years old) and is registered under CIN U24290DL2021PTC376373.
Cavaxa Biotech has 2 current directors:
- Jayram Kumar - Director
- Santosh Kumar Singh - Director
The latest financial statements of Cavaxa Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 17 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Cavaxa Biotech is U24290DL2021PTC376373. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cavaxa Biotech was incorporated on 02 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Cavaxa Biotech by revenue are Gaarnis Pharma Private Limited, Genex Laboratories Private Limited, Aydis Labs Private Limited, Metafaabex Industries Private Limited, Manish Biochem Products Pvt.Ltd. and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jayram Kumar was appointed as Director on 02 Feb 2021. Santosh Kumar Singh was appointed as Director on 02 Feb 2021.
Yes, Cavaxa Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0010213).
The registered office of Cavaxa Biotech is at CO Chotu Ram Sangwan Plot No – 4 FF Dewan Estate Bhagwati Garden Uttam Nagar, New Delhi, Delhi, India – 110059.
Cavaxa Biotech operates in the chemicals industry, in the other chemical product segment.
Cavaxa Biotech can be reached at its registered office: CO Chotu Ram Sangwan Plot No – 4 FF Dewan Estate Bhagwati Garden Uttam Nagar, New Delhi, Delhi, India – 110059.

